Found: 20
Select item for more details and to access through your institution.
Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Follow‐up of SARS‐CoV‐2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 5, p. 2925, doi. 10.1002/jmv.26810
- By:
- Publication type:
- Article
A cross‐sectional community‐based observational study of asymptomatic SARS‐CoV‐2 prevalence in the greater Indianapolis area.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 11, p. 2874, doi. 10.1002/jmv.26182
- By:
- Publication type:
- Article
Once‐weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3020, doi. 10.1111/dom.15604
- By:
- Publication type:
- Article
Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1753, doi. 10.1111/dom.14760
- By:
- Publication type:
- Article
Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1493, doi. 10.1111/dom.13668
- By:
- Publication type:
- Article
Effect of once weekly dulaglutide by baseline beta‐cell function in people with type 2 diabetes in the AWARD programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 8, p. 2023, doi. 10.1111/dom.13313
- By:
- Publication type:
- Article
Effects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 3, p. 436, doi. 10.1111/dom.12816
- By:
- Publication type:
- Article
Baseline factors associated with glycaemic response to treatment with once-weekly dulaglutide in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2016, v. 18, n. 11, p. 1138, doi. 10.1111/dom.12702
- By:
- Publication type:
- Article
Cardiovascular safety for once-weekly dulaglutide in type 2 diabetes: a pre-specified meta-analysis of prospectively adjudicated cardiovascular events.
- Published in:
- Cardiovascular Diabetology, 2016, v. 15, p. 1, doi. 10.1186/s12933-016-0355-z
- By:
- Publication type:
- Article
Acute heme oxygenase inhibition does not alter afferent arteriolar responses to angiotensin II or increases in perfusion pressure in normal kidneys.
- Published in:
- FASEB Journal, 2007, v. 21, n. 6, p. A844, doi. 10.1096/fasebj.21.6.a844-d
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 2, p. 637, doi. 10.1007/s13300-018-0377-5
- By:
- Publication type:
- Article
Indicators of Kidney Fibrosis in Patients with Type 2 Diabetes and Chronic Kidney Disease Treated with Dulaglutide.
- Published in:
- American Journal of Nephrology, 2023, v. 54, n. 1/2, p. 74, doi. 10.1159/000529374
- By:
- Publication type:
- Article
Dulaglutide and Kidney Function–Related Outcomes in Type 2 Diabetes: A REWIND Post Hoc Analysis.
- Published in:
- Diabetes Care, 2023, v. 46, n. 8, p. 1524, doi. 10.2337/dc23-0231
- By:
- Publication type:
- Article
Renal Heme Oxygenase-1 Induction with Hemin Augments Renal Hemodynamics, Renal Autoregulation, and Excretory Function.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Renal Heme Oxygenase-1 Induction with Hemin Augments Renal Hemodynamics, Renal Autoregulation, and Excretory Function.
- Published in:
- International Journal of Hypertension, 2012, p. 1, doi. 10.1155/2012/189512
- By:
- Publication type:
- Article
Increase in heme oxygenase-1 levels ameliorates renovascular hypertension.
- Published in:
- 2005
- By:
- Publication type:
- journal article
949-P: Dulaglutide Improves Kidney Fibrosis Biomarker Levels in Patients with Type 2 Diabetes and Moderate-to-Severe Chronic Kidney Disease.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-949-P
- By:
- Publication type:
- Article
356-OR: Effect of Dulaglutide on Kidney Function–Related Outcomes in Type 2 Diabetes: Post Hoc Analysis from the REWIND Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-356-OR
- By:
- Publication type:
- Article
233-OR: Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-233-OR
- By:
- Publication type:
- Article